Eosinophilic droplet formation, a morphologic manifestation of cardiomyocyte apoptosis, is present in the humoral (microvascular) rejection of human cardiac allografts [2]

Transplantation

Volumn 66, Issue 3, 1998, Pages 404-405

  Beranek, Jiri T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; BLEEDING; CELL DEATH; CELL INFILTRATION; EDEMA; GRAFT REJECTION; HEART MUSCLE CELL; HUMAN; LETTER; MAJOR CLINICAL STUDY; MICROVASCULARIZATION; PRIORITY JOURNAL;

EID: 0032529626     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808150-00023     Document Type: Letter

References (15)

1. Beranek JT. Apoptosis is the main mechanism of cardiomyocyte death in the hyperacute rejection of heart xeno- and allografts. Transplantation 1997; 64: 1632.
2. Lones MA, Czer LSC, Trento A, Harasty D, Miller JM, Fishbein MC. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 1995; 14: 151.
3. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The heart and cardiovascular system, 2nd ed. New York: Raven Press, 1992: 1875.
4. Hammond EH. Pathology of cardiac vascular (microvascular) rejection. In: Hammond EH, ed. Solid organ transplantation pathology. Philadelphia: Saunders, 1994: 92.
5. Beranek JT. Terminal complement-complex in myocardial reperfusion injury. Cardiovasc Res 1997; 33: 495.
6. Fujiwara H, Onodera T, Tanaka M, et al. A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase. Circulation 1986; 73: 749.
7. 2 and C-reactive protein in the removal of injured cells. Immunol Today 1997; 18: 111.
8. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141.
9. Beranek JT. C-reactive protein and complement in myocardial infarction and postinfarction heart failure. Eur Heart J 1997; 18: 1834.
10. Beranek JT. Hyaline degeneration in heart infarction. Cardiovasc Res 1995; 29: 142.
11. Garcia-Dorado D, Theroux P, Solares J, et al. Determinants of hemorrhagic infarcts: histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol 1990; 137: 301.
12. Beranek JT. Why do channels remain patent after transmyocardial laser revascularization? Ann Thorac Surg 1998; 65: 1200.
13. Beranek JT. Pseudovascular tubes obscure transmyocardial revascularization. Ann Thorac Surg 1997; 63: 597.
14. Beranek JT. Laser-mediated transmural myocardial channels induce a hyalin degeneration of neighboring myocardium. J Am Coll Cardiol 1994; 23: 1518.
15. Iizuka K, Kawaguchi H, Yasuda H, Kitabatake A. The role of calcium activated neutral protease on myocardial cell injury in hypoxia. Jpn Heart J 1992; 33: 707.